HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 28% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

 
Press Releases  

Zacks Analyst Blog Highlights: Coventry Health Care, Inc., Aetna Inc., Unitedhealth Group, Inc., WellPoint Inc. and Expedia

November 02, 2009 | Comments: 0
Recommended this article (1)
CVH | AET | UNH | WLP | EXPE
Print    Share

For Immediate Release

Chicago, IL – November 2, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Coventry Health Care, Inc. (CVH - Analyst Report), Aetna Inc. (AET - Analyst Report), Unitedhealth Group, Inc. (UNH - Analyst Report), WellPoint Inc. (WLP - Analyst Report) and Expedia (EXPE - Analyst Report).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s AnalystBlog:

Coventry Beats Expectations

Coventry Health Care, Inc. (CVH - Analyst Report) reported third quarter earnings of 66 cents per share, which was above the Zacks Consensus Estimate of 54 cents. The company earned 73 cents in the year-ago quarter.

Total operating revenues for the reported quarter increased 17.8% to $3.44 billion from the previous year's $2.92 billion. Revenues from managed care premiums rose 20% to $3.15 billion, while revenues from management services decreased to $290.9 million from $298.4 million a year earlier.

Due to reduced commercial risk and commercial management membership, total enrollment in Coventry plans increased 0.55% to 5.24 million members, mainly on gains in the Medicare D prescription drug program. The membership in that program increased 81,000 from the prior quarter.

Total operating expenses for the quarter came in at $3.29 billion, up 18.6% from the year ago quarter. Medical costs, the major operating expense component, rose to $2.66 billion from $2.20 billion last year. The medical loss ratio for the quarter (the proportion of premium revenue spent on providing medical care) reduced to 84.4 % from 86.4%.

For the quarter, Coventry Health displayed continued growth in all Medicare products, with Medicare Coordinated Care Product (CCP) membership rising 38% from the third quarter of 2008. The commercial group risk premium yields rose to $304.13 per member per month in the quarter, which reflected a 6.1% increase from the year-ago quarter.

Coventry ended the quarter with $1.71 billion cash and cash equivalents. Furthermore, Coventry exited the quarter with $1.71 billion in long-term debt. Coventry raised its fiscal 2009 earnings guidance to $2.01-$2.03, from the prior guidance of $1.85-$1.95 per share. The guidance excludes the impact of the First Health Services Corporation (FHSC) divestiture.

Coventry operates as a managed healthcare company in the United States. The company operates local health plans that serve markets primarily in the Mid-Atlantic, Midwest and Southeast United States. The company competes with big players like Aetna Inc. (AET - Analyst Report), Unitedhealth Group, Inc. (UNH - Analyst Report) and WellPoint Inc. (WLP - Analyst Report).

Currently we are Neutral on Coventry shares.

Expedia Beats on Higher Volumes

Expedia’s (EXPE - Analyst Report) third quarter earnings beat the Zacks Consensus Estimate by 15 cents. Revenue beat by 2.8%.

Revenue

Revenue for the quarter was $852.4 million, up 10.7% sequentially and 2.3% year over year. Acquisitions had a 1.7 pecentage point positive impact on revenue in the last quarter.

Leisure customers remained the largest revenue contributors, generating 86.1% of revenue. Corporate customers (Egencia) generated 3.0%, while TripAdvisor brought in the remaning 10.9%. The three categories increased 11.4%, 0.0% and 83.0%, respectively from the June quarter of 2009. They also increased 2.7%, 0.0% and 67.2%, respectively from the year-ago quarter.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

 

 


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Free Stock Analysis From Zacks
  Includes Zacks Long-Term Recommendation and Target Price
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Feb 10, 2010 07:34 am ET
DJIA 10058.64  0.00 0.00%
NASD 2150.87  0.00 0.00%
S&P 500 1070.52  0.00 0.00%